Healthcare, Automotive, Technology Mar 11, 2022 05:29 PM (GMT+8) · EqualOcean
Shanghai Pharmaceutical announced that recently, the wholly-owned subsidiary of Shangyao Xinyi received the notice of approval of drug supplementary application for methotrexate tablets (Notice No.: 2022b00974) issued by the State Food and drug administration, and the drug passed the conformity evaluation of generic drugs.
Related companies: